International Stem Cell (ISCO) Current Assets (2010 - 2026)
International Stem Cell's Current Assets came in at $3.92 million for Q2 2026, up 2.1% from $3.84 million a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, International Stem Cell's Current Assets was $3.41 million, down 4.2% from FY2024.
- Current Assets carries a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
- Going back by year, Current Assets was $3.56 million in FY2024 (+1.1%), $3.52 million in FY2023 (+18.8%), $2.96 million in FY2022 (+26.9%) and $2.33 million in FY2021 (+6.9%).
- The Q2 2026 figure represents the highest quarterly Current Assets since Q3 2018.
- Year-over-year, Current Assets increased in five of the last seven quarters, with growth averaging 1.3%.
- The fastest year-over-year change in Current Assets over five years came in Q3 2023 (growth of 35.5%), and the weakest in Q3 2021 (a decline of 5.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | International Stem Cell | 1.36 Mn | -2.61 Mn | 1.46 Mn | 3.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.92 Mn |
| Dec 31, 2025 | 3.41 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 3.84 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Dec 31, 2024 | 3.56 Mn |
| Sep 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 3.82 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Sep 30, 2023 | 3.66 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 3.24 Mn |
| Dec 31, 2022 | 2.96 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 2.99 Mn |
| Mar 31, 2022 | 2.96 Mn |
| Dec 31, 2021 | 2.33 Mn |
| Sep 30, 2021 | 2.49 Mn |
| Jun 30, 2021 | 2.79 Mn |
API Access
International Stem Cell Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();